To my layman's eye the MBA change index results are a no brainer that this has a measurable effect. From what I see the CSS change index is based on less specific indicators of efficacy than the MBA index, and I can see how they might not indicate much difference to placebo. Have a look at the list of items in the right column.
The MBA results start returning to the placebo group at day 26 when the treatment finishes. What am I missing? Other than it was a debacle for the share price when it got knocked back, I would be inclined to assume this was a "breakthrough therapy". If my daughter was needing it I would be pretty annoyed waiting for FDA statistical analysis to catch up.
If I am showing my ignorance please feel free to point out the errors!
Cheers and good luck to all.
Ann: Neuren presents at Rettsyndrome.org 2016 Research Symposium-NEU.AX, page-2
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.97 |
Change
0.000(0.00%) |
Mkt cap ! $2.552B | |||
| Open | High | Low | Value | Volume |
| $19.96 | $19.97 | $19.69 | $4.156M | 209.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 246 | $19.88 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.99 | 512 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |